University of New Mexico: FDA Endorses Drinking Reductions as Valid Clinical Endpoint in Alcohol Use Disorder Trials Researchers Review
September 18, 2025
September 18, 2025
ALBUQUERQUE, New Mexico, Sept. 18 -- The University of New Mexico issued the following news:
* * *
FDA endorses drinking reductions as valid clinical endpoint in Alcohol Use Disorder Trials Researchers Review
UNM Distinguished Professor Katie Witkiewitz leads review focused on WHO Risk Drinking Levels
By Steve Carr
In a significant advance for the treatment of Alcohol Use Disorder (AUD), the U.S. Food and Drug Administration (FDA) . . .
* * *
FDA endorses drinking reductions as valid clinical endpoint in Alcohol Use Disorder Trials Researchers Review
UNM Distinguished Professor Katie Witkiewitz leads review focused on WHO Risk Drinking Levels
By Steve Carr
In a significant advance for the treatment of Alcohol Use Disorder (AUD), the U.S. Food and Drug Administration (FDA) . . .